PELVIC RADIATION DISEASE ASSOCIATION Annual Report 2021-2022
Contents
3 3 Legal & Administrative Information 3 Foreword 4 Introduction 5 About the PRDA, our aims and objectives
6-7 Highlights of 2021-2022 8 Our year in numbers Patient stories 9 10 A summary of our plans for the year ahead 11-13 Report of the trustees Financial review 14-22
02
Legal & Administrative Information
Registered Company number: 07998409 (England and Wales)
Registered Charity number: 1147802
Registered office: 62 Norbiton Avenue, Kingston upon Thames, Surrey, KT1 3QP
Chair:
John A Webber
Trustees:
Alison S Boyes David E Jillings Dr Lisa A Punt Dr Benjamin D Sacks Bhumi Shah Dr Lesley Smith Company Secretary: D E Jillings
Independent Examiner Details:
Mary E Ryan FCCA, CertPFS, DChA
Ark Accountancy, Chartered Certified Accountant, 31 Cheam Road Epsom Surrey, KT17 1QX
Foreword
Samantha Bostock
In my role as a Late Effects Lead Radiographer, I have seen first-hand the incredibly debilitating impact Pelvic Radiation Disease can have on people in the months and years following radiotherapy for pelvic cancers. It can destroy quality of life due to the physical, emotional, and psychological impact of symptoms in so many ways – people are unable to leave their homes, work or continue relationships. Symptoms can be distressing and life-changing following cancer treatment – and often devastating in their severity.
The work of PRDA means that people feel less alone. The charity helps people to understand and take control of their symptoms and gives people the confidence to ask questions of their healthcare team. The work this charity does to raise awareness and support both people living with PRD and their carers is wide-ranging and invaluable. They give a voice to people with PRD.
Equally important is their work with health care professionals who work with people experiencing PRD to improve their symptoms and quality of life – not to mention those professionals who are unaware of PRD, which is a far greater number than we might like to think. PRDA’s support is instrumental in building radiotherapy late effects services, and in developing the resources we need to ensure our patients receive the best care possible. It is vital that PRDA continue to receive support so they can build on the vital work they do in raising awareness of PRD and its management. I very much look forward to continuing to work with them over the coming year.
03 02
John Webber - Chair of Trustees
In 2021/22, against the backdrop of the nation coming out of lockdown, PRDA continued to grow while putting into practice all we had learned during the coronavirus pandemic.
Being forced to move our support services online had been a revelation for the organisation, and we have continued to offer fully remote support to patients over the past year. As ever, we have divided our focus into two key areas: direct patient support, and professional engagement.
Our online community and remote support offerings have continued to grow steadily, while our ground-breaking Out and About Toolkits, launched in December, have quickly become a cornerstone of our work.
Alongside our support offering, we have also launched our volunteering programme, and now have 14 volunteers. Most notably, we established our Patient Advisory Group – we thank them wholeheartedly for their feedback and consultancy throughout the year.
we feel a great responsibility to give a voice to people living with PRD, and we are now more dedicated and focused on these aims than ever
Our professional engagement programme has continued to build off of the successes of last year’s Annual Conference, and we look forward to launching our new Best Practice Pathway later in 2022. This will be a pioneering piece of work and has taken huge effort from our Trustees Dr Lesley Smith and Dr Ben Sacks, alongside countless hours contributed by our network of health professionals. The document will be launched at our conference in the autumn and is set to be a ground-breaking moment for the organisation.
As ever, we are incredibly grateful to our supporters and donors for the contributions they have made to fund our critical work. As an organisation, we have grown our turnover year-on-year since our formation in 2012, and we now feel that we are uniquely well-placed to support people living with PRD. It is because of this that we feel a great responsibility to give a voice to people living with PRD, and we are now more dedicated and focused on these aims than ever.
Thank you.
04
The Pelvic Radiation Disease Association gives a voice to people affected by Pelvic Radiation Disease, an extremely debilitating condition caused by radiotherapy treatment for cancer in the pelvic area. By offering information, peer-to-peer support, and advocacy for patients, we improve quality of life for people who have been treated for cancer but are now living with the consequences.
We exist to help the estimated 100,000 people in the UK who had been hoping to get back to a normal life after cancer but are now living with PRD. The disease can destroy a patient’s quality of life due to difficulties with bladder and bowel control, sexual function, fertility, and mobility, as well as social isolation and mental health issues.
The key objectives and outcomes of our work are:
Outcome Performance indicator Fewer people feel alone while experiencing the Increasing the number of patients engaging with our direct debilitating symptoms of PRD support offerings, including the Chat Together support groups, Online Community, and new one-to-one support pilot project. Better information is made available to We are producing new literature for patients and will patients in advance of radiotherapy treatment disseminate the most up to date PRDA information to as many people affected by PRD as possible. Better understanding among health Bringing together greater numbers of health professionals to professionals who are treating people with PRD engage in conversations about PRD, launching the Best symptoms Practice Pathway to the widest possible audience and seeing increased engagement with our resources for health professionals. Reduced stigma associated with having longMore usage of our Out and About Toolkits to give people term, embarrassing symptoms after cancer more confidence in managing their symptoms, and access to treatment patient stories and peer support to help people know they are not alone. Wider awareness of PRD in the medical and Widening our corporate network of companies working in research community and evidence of the need these fields, strengthening our relationships with other to conduct more research on how to prevent charities working in the sector, and growing our network of and treat PRD health professionals. Establishing Pelvic Radiation Disease
Widening our corporate network of companies working in these fields, strengthening our relationships with other charities working in the sector, and growing our network of health professionals. Establishing Pelvic Radiation Disease as an accepted term and getting it included in data collected by clinics.
Improved quality of life for people affected by PRD.
Increased uptake of our support services. Regular discourse and consultation with our Patient Advisory Group in all areas of our work to ensure we are offering people affected by PRD the help they want and need.
05
Growth of the volunteering programme and PAG
Since recruiting a Services and Volunteer Officer, we have been able to launch our volunteering programme and Patient Advisory Group quickly, and they are now central to our success. Our Patient Advisory Group now has eight members, and they feed into many areas of the organisation’s work, to reflect the voice of people living with PRD. We thank them for their efforts over the past year.
Out and About Toolkits
Our new Out and About Toolkits are filled with useful information, tips, and items to help people with PRD have more confidence when leaving the house – something which can be extremely challenging when struggling with PRD symptoms. We were thrilled to see our initial pilot run of 100 packs – funded by the National Lottery – run out within five weeks back in December 2021, and we are now planning to distribute another 300 packs before the end of the financial year.
Professional engagement
The majority of our focus has been the production of the Best Practice Pathway for Pelvic Radiation Disease, a reference for any clinician who encounters PRD. In order to create this resource, we have been working closely with clinicians and academics up and down the country.
PRDA has also had abstracts and poster presentations accepted at clinical conferences. This is an excellent opportunity to meet and exchange ideas with others working in PRD.
06
Growth of all platforms and service offerings
Our network of supporters, patients and professionals has continued to grow steadily as we expand our reach and diversify our work.
We have seen rises in all metrics across our online platforms and channels, and our Online Community and Chat Together groups are experiencing higher levels of engagement than ever. Our online community has grown to 297 members and has had an amazing 38,000 page views.
Visits to our website were up by 65% compared to the previous year and our social media followers have increased by 34% which we are really pleased to see. We are always looking for new ways to support people with PRD, and these channels are what allow us to do that.
Surpassing income targets
Despite setting a higher target than ever before and forecasting an acceptable operational loss for the financial year, 2021/22 broke all records for income for PRDA. This was in large part due to a donation of £10,000 from Aspire Pharma, to help us fund our upcoming Best Practice Pathway and Annual Conference. We also saw record income from regular and individual donors, and we thank everyone who chose to contribute to PRDA in the last year.
Operational improvements
Over the previous year we have made a number of important internal changes to improve our operational processes.
We now have three part-time members of staff covering three distinct areas of operation: Marketing and Communications, Fundraising and Events, and Services and Volunteering. As a result, we are expanding our work quicker than ever, and our staff can now focus more on their particular areas of work.
We have introduced a Client Relationship Management system to help us capture more and better data, which will inform our work in the future. While it can be a long process to introduce a new CRM, we are already noticing the benefits of more streamlined data capture.
Alongside the introduction of the CRM, we have also moved to Microsoft 365 to enable better remote and asynchronous working. Since the pandemic, we have moved to a fully remote working process with members of our team and Board located in many different areas of the UK.
07
Our year in numbers
Social media followers up 34% Over 350 professionals and patients attended our first digital Annual Conference
Over 11,000 visitors to our website
an increase of 65%
152 Out and About Toolkits provided
27+ hours of 297 Online Our online sessions for our Chat Community members community for Together service people living with Pelvic Radiation Disease also had 38,0000 page views
08
"The patient stories on the PRDA website have repeatedly reminded me that I’m not alone, and that I’m not imagining the symptoms I’m living with. Persistent pain without an obvious injury than can be seen is hard for people to understand, including in your own mind, and I’ve often wondered if I’m somehow making it worse than it really is."
Rebecca's Story
I was diagnosed with colorectal cancer in March 2017 and 6 weeks of radiotherapy started in May of that year.
I was given the all-clear in 2018, from the colorectal cancer, but two weeks after that all-clear I was rushed into hospital with severe kidney pain, due to a blockage. The consultants then told me that I now had a life-long issue, because the radiotherapy had caused scar tissue in the ureter, between the kidney and the bladder.
Hearing the consultant say that the radiotherapy had caused the blockage really set me back.
PRD has such a varied number of symptoms. I’ve also had a kidney removed because of it. Generally, it’s quite difficult; you can be on the toilet all day, or you can be in agony because you’re not going for four or five days.
The biggest impact that PRD has had on me is the shock of being taken into hospital after being given the all-clear. When you realise that the radiotherapy has caused such serious issues, your mental health just plummets, because it’s so unexpected.
PRD is worse than the cancer, and I was totally unprepared for it. It's such a rollercoaster and just so unexpected.
People do need to be aware, that, if there are issues, you can get help.
Finding PRDA made me feel so relieved. Suddenly, you’ve got a great big hug! It’s not just you, there are other people like you. There’s a group of people that know exactly what I’m going through. The PRDA want to help others; they want to educate health professionals.
My big message to other people who might be experiencing late effects symptoms – whether they have a PRD diagnosis or not – is that you are not alone.
09
Services
Let’s Talk programme
In 2022 we received grant funding from the National Lottery Community Fund to set up a new programme to help people experiencing PRD for the first time to better understand their symptoms, and how to manage them.
Volunteering
Continue to build the volunteering programme We will increase our range of opportunities to volunteers and develop our volunteer resources hub so we can better support the people who give up their time to support us.
Professional engagement
Best Practice Pathway
We will launch a pioneering document outlining pathways of care for people with, or at risk of, PRD, that we have developed in conjunction with leading experts in the field of pelvic radiotherapy.
2022 Annual Conference
The launch of the Best Practice Pathway will happen at our Annual Conference, as we bring together patients and professionals to discuss treatment and diagnosis of PRD.
Awareness
Increasing reach
We will continue to focus on expanding our reach through social media and leaning on our partners to help us spread information about PRD further.
Better information
Our Best Practice Pathway for Pelvic Radiation Disease and its accompanying literature will help both healthcare professionals and people affected by PRD to better understand the condition and the care options available.
Fundraising
Increasing and diversifying income
As an organisation we have grown our turnover steadily yearon-year since forming in 2012. Our focus is now to build a long-term, sustainable fundraising strategy that will allow us to scale up all our service offerings.
10
PELVIC RADL4TION DISEASE ASSTIoN Report of the Tn for the Yegr Etthd 31 March 2022 The tsi]stees are alw deCtOrS of the chan"t! for the Pur[ of the Compames Act 2(M)6. present their report llth the financ1 statements of the chanty for the sear ended 3 1 March 9022. The tnlstees hai"e adopted the proiisions of Account8 and Repg bi. Chan'ties". Statement of Recotnmended Practtce applicable to chan'ties prepanng their accounts in aCcOrde Thith the Financial Rert8 Standard apph'cable in the UK aThl Repubh'c of Ireland (FRS 102) (effethi:e l January 2019). OWECTJIIS thT) ACTtITtIES Objectfii'es and aims The terni Peli'ic Rthts"on Di8eAxe 18 st to 8Am Acceptance among beAIth profe88ionAIs and useful framerk Thlllch to describe trnef or lon8 lastsn8 problenLS. mostty in the boii"el. eaused b). peli'ic rathotherapy. The ttustees alln to brm8 this thSe to the attentioo of heahh professionals and patients lo Jnforni thern about hoTh to allei.iale the sjinptorns. The trustees to hai"e the mosl up to date InfornlIon for patsents on the i'anous aspects of PelNic R2th'ation Disease and ai"ailable resources for treatment. The objectii'es of the charity as per the Articles are.. To can1w for the Hider r08" of Peliic Rath"ats"(m Dtsea8e well as f tsnEYo1'ent Natsonal Health Sernice facihtses ond treatsnet)t to help Ik rnant of rathatson Anded injury. To support pats.ents sufferin8 from rAthabon ]nded injury and m pae13r patseots suffenng from Peliic RadAats"on Disease in any appropnate includJn8 throu8h a netwThk of Jnfornd support 8TOUPS that gre professionally supported. To 8ather inf0mtion about and supp)rt researeh itito Peliie Radiati'¢)n Diseaye. Slgnlflcint lcthrltles Founded theen )'ear5 a80 as a patient support 8roup and reStered as a cftjarity in 2012, the tnS continue to dedicate themseli'es, 7th the support of i"oluateers. to expand the outreach of the Peli'ic Rath'ation Disease AS&clatIOn (PRDA) and to fiulher re[ll the chanty's FWI.l0n of ll]fOrnutso Sup¢ and gwdelllJe$ to both patsents and health professionals. REIIEM: The year started ii'ith an ambitious spending larpet gnd the possibility of a small and acceptable operating loss oi'er the period. FUnd"s8 managed to exceed expectatsorL8 and match st. resulbn8 in a )'e8r a record turnoi'er by sorne cotL8iderable mar8An but also a small increase in futth m the bat)L Flllanclal Posl¢lon The gross Income of the ehanty for the Jear etmled 31 March 2022 amounted to £41,399 (2020121. £28,391) N'hereas Costs for chgntable actiiits'es m.ere £38:018 (2020.21." £30,938), of l'ch GONernae costs were £640 (2020121: £620). The net surplus for the )ear 7S £3.381 (2020,21: deficit £2.547) The oN'erall net assets of the company hlli"e inc9Sed from £42.(H9 to £45.430. Resen"es pollc). It is the l1¢Y of the tswtees to majntam unre8tnct&l fu, Htllch are the free reseTh of the chanty, at the minimum leNtl of £lO,(KK). 11
PELVIC RADIATION DISEASE ASs(TIoN rt of the Trustees for the Year Ended 31 March 2022 STRicfLIiE, GOITRNL)CE AND LILLYAGLIIENT GoTrerDlug do(ument The Chanty established under a Metnordnth of Association thieh establ the obj.eets of the ehantable company, and is goiErned ullder its Arts'cles of AsSlla.o The chan.ty is goi'erned b)" the Board of tnlstees: Mlu'ch meets on a regular basis. The secretary. and the trustees rnanage all da) to da) operdtions of the chanty and support and athise on all fancL matters. The chty is restered iiith the FUndrS8 Regulator Recrnitment and Appointment of new trnstees Trugtees reeeii'e llritten minutes &t Board MeetlD8s beld the y&qr to ensure they Are kept up to d&te the cts"i'itse% of the eh2n"ty'. In the tsIL8tees reiieu. The Peliic RAth2tion Disease As19ti.0ll 0"0 of whcie8 and pr(tedures on a regular basis, and trCjee nem. wh.cies and pr(edure$ as appropnth. Mr Willie Auld resigned as a tsu8tee 2011212021. Related partles The Charit)" has no subsidiaries. There are no related Pe8 in the clwity. Rlsk management The ttustees hai"e 18sessed the n)aJor nsks to thch the Chgnty exposrf Jn pa"CUlar those reled to the orffitson and fmances of the eh2n"ty, oJ]d are tsSfied that the s)stems are m place to mits8ate ther exFKJsure to the mAJor risks. Efforts 8re eonlAnuol). made to ere&se fiu]ds. loternal nsks aTr miDuwed bi, u))plen)entation of satssfactory oteratsonal procedures, and con$tellt quahty, of senice deliiw. These are reiieiied by the Board on a regular basts. PRDA doe& hold any miystnwnts. REFERENCE ADIILN1STRATJIT DETAIIS Reglslered CompaD)' Dutllber 07998409 (En8land and 11:ales) Regtslered Chartty. number 1147802 Reglstered omce 62 Norbiton Ai'enue Km8Ston upon Thame¥ KTI 3QP Tru5tee5 W Auld (resigned 20.12.21) D E Jillmog DrLAPunl DTB D Sacks B K SR)ah DrLMSmith J A Webber (Chair) MSAS Bo)es CompallTr Secretary D E J1]ng8 12
PELVIC IIADIATION DISE4SE ASSOCIATION rt of the Trustees for the Year Ended 31 March 2022 REFERL)CE AD)ILNISTRATtIl DETAILS Independent Erniner Matv E Rl'an FCCA, CertPFS, [lL4 Ark Aeeountsney Chartered CefIed Accountant 31 Chegm Road Epsom KT17 IQX Approi'ed by order of the br)9 of tnlee¥ on 12 Au8USt 2022 and signed on rts behalf by: D E Jillin8s- Trn5tee 13
ndent Examinerf$ Re rt to the Trusteeg of PEL VIC RADL4TION DISEASE Ass(lATIoN Independent examiner's report to the trustees of PELIIC liADIATIo DISEASE ASSOCIATION Cthe Compan)-') I report to the chty trtee$ on my exatlltstiOll of the accounts of the CoMnY f(r the year entsj 31 March 2022. Responslbllltles and ba51s of ttport AS the charity's trustees of the Company (and also Its the PWFX)w of conw} laTh) you are responslble for the preparation of the accounts in accordance Thith the reqUIr of the CompHmes Act 2006 (the 2(K)6 Acf). HaN'ing satssfied mjself that the accounts of the C(ttnpan) are not requwed to be authted Part 16 of the 2006 Act are e.ble for indeEtht examJnkn'oTr I rert In respect of m)" examination of )our chanty's accounts as camed out under section 145 of the Chantses Act 2011 {'the 2011 Act,). In carrytno out my £xanOn I hal'e followed the DectionS gii'en by the Chanty Commission under sectson 145(5) (b) of the 2011 Act. IDdependent examlnefs statement I hai'e eompleted m) exaMmatso I confirm that ntter$ h'e come to my attents.on io connection 7th the ex2mitiation 811'in8 me cause to be.'e.. accountm8 rec¢)rd3 Ere not kept in restttt of the Compw as required by svtson 386 of the 2006 Act" or the accounts do not accord Mith those recordg. or the accounls do not conwl}' INith the acco requirements of section 396 of the 2006 Act other than any requirement that the accounts 8ii.e a tn and fw lie mlll.ch is not a matter considered as part of an depdent examllo. or the acCOt$ hai"e not been prepaTrd in accordance Thith the methods and principles of the Ststemenl of Recommended Practice for aCCountll and reportm8 bj. clwities (applicable to charits'es prepann8 their accounts m accordance Mith the Financ Rep)W Standard applicable m the UK and Republic of treland (FRS 102)). I hai'e tjo coneem$ and have cotne acros8 no other t))atter8 m connectson Thith the examtsutson to Thlll"ch attentson should be reE in order to enable a proper uthtaTrJmg of the accounts to Ee reached. Mary E R}'an FCCA, CertPFS, [A Ark Accountancy ch8rttt Cetrtsfi Accountaot 31 Cheam Road Epsom KT17 IQX Date: ............................................. 14
PELVIC RADIATION DISEASE ASS(lATIoN Statement of Financial Actiiitses for the Year Ended 31 March 2022 31_3_22 Total 31.3.21 Total Ncles L%CO FROII Donats¢)n$ aj legacies 7.829 7,829 6,362 Charltable adhrltles pengull against wcer DaiNille Trust P F Trust Gisella Gralwn Foundatson National Lottery Community, Fund The Ivoodroffe Benton Foundation Lennox Hanna) Chantable Tnt National Lottery. Local Commuwty Fy1 H08pilal Saturda) Fund Community Local Connect Aspire PhaJTaa 5,000 1,000 3.000 1.000 4.400 500 1,000 2,486 2,450 2,450 io,¢x io.(v) Other trathn8 actii'its"e8 Total 38.949 2,450 41.399 28.391 EEN1)ITlryIE O Cbarllable acthltles Chantable actii-itie8 Lennox Hannaj Cbantsble Trust Community Fund L(tal Connect 32.671 32,671 1,795 3,552 30,938 1,795 3,552 Total 32,671 5?47 38,018 30,938 NET L%COlE/(EXPEND[[L1IE) 6278 (2,897) 3.381 (2,547) Trallsfer5 1)etween funds io (4 413) et movement In funds 10.691 (7,310) 3,381 (2.547) RECONCILIATION OF FLryDS Total fuDd5 brought forTrvard 34,739 7JlO 42,049 44,596 TOTAL FiTrI>S CARRIED FORII'ARD 15
PELVIC RADIATION DISE4SE ASSOCIATION Bthee Sheet 31 Mareh 2022 31_3_22 Total 31.3_21 Total funds Un[eseted Restncted Notes CLryUiENf ASSETS Debtors Cash at baDk 150 150 47 605 100 207 47,548 207 47,755 44,628 CREDrroRS Amounts fallAn8 due one year (2.118) (207) (2,325) (2,579) NET CLUUiES7 ASSETS 45,430 42,049 TOTAL XSSETS LESS CLIUiENT LL4BILrriES 45,430 45,430 42,049 NET ASSETS io Unrestncted Restncled fid$ 45,430 34,739 TOTAL FLThT)S The chgntable company 1$ entstled to exthDpts from audit 477 of the Cthnplmes Att 2006 for the ye8r ended 31 Manh 2022. The members hai"e not requ the compan) to obtajn an auth't of its fiDancial ststements for the year ended 31 March 2022 accordat]ce with Sects(rt] 476 of the Compgmes Acl 26. The trustees ackn0.1ed8e their responsibthts'es for (a) ensuring that the ehantable compon) keeps aOttn8 rordS that comply 7th SpLtsons 386 and 387 of the C¢)mp8meg Act. preparing financial statements *'ch 4ii"e a t and fw iiem" of the state of affaS of the clwitable compgn) ag at the end of each flljancl )ear and of its surp] or deficit for eAch financial )egr m accordance llth the reqUements of Sections 394 and 395 and iNlll"ch otheThi8e compl} uith the requrements of the Compames Act 2(K)6 relatsn8 to fiDancial stateffjents. so far as apphcable to the chantable conipally. (b) 16
PELVIC IVL4110N DISEASE AsS(L4]IoN Balance Sheet- contmued 31 March 2022 The8e financial 8tstellts hai'e been prepTrd in acCOrde the Froivions opphcable to ch8n'table cotnpames subject to the small eomparnes re8Jme. The fllwieiai Statements were apFWI'ed by the Board of TnLStees and authonsed for tssue on 12 Au8llSt 2022 and were signed on its behalf by: D E - Tnlee J A Webber- TDJStee 17
PELVIC RADIATION DISEASE ASS(ThTION Notes to the Financial Statements for the Year Ended 31 Maffh 2022 AccoEiiYfLNG POUCIES Basis of prepATing the fmAnc1 stxtements The fU)ancl statements of the chantable con)pany, ll"ch a pubhc benefit entsty under FRS 102, hai'e been prepared accordance Mith the Chanties soiisl IFRS 10?) 'Accountmg and Reportmg . Chanties". Statement of Reconjmended Practice apphcable to cbantses preparll]g ther aceouThts in accordance iiith the Fllwicial Reportin8 Standard applieable in the and Republie of Ireland (FRS 102) (effeetsi'e l January 2019),, Financial Reporting Standard 102 'The Financ1 Re). Standard apphcable in the UK and Repubhc of Ireiand, and Ihe Compames Act 2CQ6. The Statements hail been prepared utth the htOrical cost conN'entio IDcome All income is in the Ststement of Actsiitses (w the ch8nty has entstlement to the fimds, it is w)bable that the wcome wlll be receii'ed al the amount can be measured rejthbl). Expenditure Liabiljties are reco8rnsed as expenditure as scx)n 85 there is a legal or construets"i'e obli8ats.on eommitting the cl)2nty to th&t expetttre, it is probable that & tr8wfer of economic benefits Mill be tpquwed in gettlement 2nd the amount of the oblJ8alion can measured reliabl).. Expthtrjre is accounted for on an aecnJal$ basis and has been clL8sified under headmAs that ag8re8ate gll cost related to the categoT)'. Where costs eannot be djrectly attn"buted to p9CUlar heath8s the) bal'e tell all(Lqted to acts"iits"e8 on a bas eonsknt 7th the uge of resources. Tangible nxed assets Depreciation is proiided at the folloMin8 annual rates in order to Tllte off eh asset oN'er its estwnated useful Website 33YD Ott e03t Tixatlon The chanty is exempt from cO)ratiOn tsx on rts charitable actiiities. Fund iccountlng Unrestn'cted funds ean be In accord8e 7th the dwi'table ObJtIlS Lt the diserets'on of the tnlsteeg. Restneted fiJnd8 can onl}. uged for partscular restncted pUrse8 the objects of the chanty. Res'cli0ns arise spec b) the donor or ii*Aen are raed for particular restn'cted purposes. Further explanation of the nath and purw8e of each fulld is the notes to the financial Statements. Pellslon costs and other pOst-tIrneD¢ beneflts The chan"tsble compan)" operdtes a defined contnbuti¢)n pS1On scheme. Contn"buts"ons pa}able to the chantable coll4Mn)'S FEllSiOn SChell are charged to the SIatellnt of Firwicl Acts"iutses in the penod to Th4llch they relate. 31_3_22 31.3.21 Fundrn"5llw "etsts Other income 11,814 306 7,368 12,120 9,643 18
PELVIC RADIATION DISEASE ASS(rnTION Notes to the Finoncial Staten)ents. contjnued for the Year Etthd 31 Mareh 2022 ET L%COIEJ(ExPL¥DfEE) Net incom&(ex)lUre) is stated after chwng(crethtmg)'. 31.3.22 31.3.21 Deprecthts"on. owned assets There ivere no trustees. remuDeration or other Eenefits for the year ended 31 March 2022 nor for the year ended 31 March2021. Trnstees. expenses There no tnL8tees' expenses to trustees in their role as trustees for the year ended 31 March 2022 nor for the year ended 31 Moffh 2021 STAFF COSTS The ai'erage monthly number of employee8 (hmn8 the Y wa8 a8 follo. 31.3.22 31.3.21 Admmistrator No employees reeeii'ed emoluments m exee89 of £60,IMI. COL%IPARATI1s FOR THE STATEIIENf OF FLILNCIAL ACmTfiES Unrestncted Restn'cted fimd Totsl fimds ¥COME A7> ENDOIITrNfS FRO.11 Donatsons and legacie8 6.362 6,362 Charltable acthfjtles PFTt Gisella Graham Foundation National Lotiery Community Fund The Wocthoffe Benton Foundatton Lennox Hanna) Chan'tsble Tn1 National Lottery Local CoMmuty Fund 3,OC(I I,oc 3,0 1,0 4,4(M) 5(K) I,O(M) 2,486 4.4 5(X) I,O(K) 2,486 Other tradmg acts"i"itie8 9,643 9,643 Total 20.505 7.886 28,391 EXPE1lTL7IE ON Charltable acthltles Chan"table actsi'itse8 23,788 7.150 30,938 ET COlEJ(XEND[rlrylE) (3283) 736 (2,547)
PELVIC RADIATION DISEASE ASS(XIATION Notes to the Financ1 Statements- eont]nued for the Year Etthd 3 1 March 2022 CO.IIPARATIIlS FOR THE STATLIIE)Y OF FL%}cL4L AcfIiTflES. continued Unrestneted Restneted fimd Totsl RECONCILIATION OF FUNDS Total funds brought fonvard 38,022 6,574 44,596 TOTAL FLThWS CARIUED FORIIARD TANGIBI FIXED ASSETS Webyite COST At l April 2021 and 31 March 2022 DEPRECIATION At l Apnl 2021 and 31 March 2022 NET BOOK I'ALL1E At 31 March 2022 At 31 March 2021 DEBTORS: IOL[s FALLLIG DIE IITfHLN ONE YEAR 31.3.22 31.3.21 150 100 CREDrroRS: MIOLwfs FALLING DI IITfHtY ONE YEAR 31.3.22 31.3.21 Soc1 security a1 other t&xes other creditors Accrued eXnge3 (538) 2.223 640 61 1,898 620 io. FLTrT)S Net nioi'ement in fimds Transfe behi'een At 31_3_22 At 1.421 Inrestrtcted fvnds General fund 34,739 6278 4,413 45,430 Restricted hnds Restncted funds 7,310 (2,897) (4,413) TOTAL FLThI)S
PELVIC RADIATION DISEASE AsS(TIoN Notes to the Fll]aJ]cial Stalements- contjnued for the Year Enda 31 March 2022 io. MOIEIIE)T ll¥ FL)I>S . continued Net moi*ment In funds, mcluded m the aimx'e are as folloM%: Incoming resources Resources expended Moi"ement in fid$ Unrestrirted Thd5 38,949 (32,671) 6278 Restricted funds Reslncted fiJnd8 2.450 (5.347) (2.897) TOTAL FlThS (38 018) Compinth'es for moi'emeDt ID fund5 et moi"ement in funds At 31.3.21 At 1.4.20 Unrestrlcted fuDd5 Geueral fijnd 38,022 {3283) 34.739 Restrtcted funds Regtncted fjjnds 6,574 736 7,310 TOTAL FEThS Comparalii'e net moi'ement In fund8, luded m the aboi'e are as followy." Incommg resources Resources expended Mm"ement in funds Unrestricted funds General fjJnd 20,505 (23.788) (3,283) Restricted ndS Restncted fid8 7.886 {7.150) 736 TOTAL FLThI)S 28,391 (30,938) (2.547) 21
PELVIC RADIATION DISEASE ASS{TION Notes to the Finaneial Ststements - continued for ttLe Year Ended 31 March 70)? io. MOITItEJT L¥ FLryTS- colltlnued A cwrent year 12 months and or )e2r 12 months conthmed tK*sits"on is as fOllm7. Net moi'ement TrdDsfers At 1.4.20 31.3.22 Unre5tiicted fund5 General fijnd 38,022 2.995 4,413 45.430 Restricted funds Restncted fill 6.574 (2,161) 14,413) TOTAL FLThT)S 834 A current year 12 tnonth and pnor year 12 mcrfth combined net mONDent in filnds. included in the aboiTe are as follow8: Resourtes exFaded Mol..eml resources Ullre5tricted thnds General fund 59,454 (56,459) 2,995 Restrlcted thllds Restncted fimds 10.336 (12,497) (2,161) TOTAL FLThI)S (68 956) 834 11. RELATED PARTY DISCLOSLryiLS EX of £2,558 'ere rellDiKr8ed to i drectsw the year (2021 £1.826 to 4 dectors) 22
PELVIC IL4DIATION DISEASE ASS[AIloN Det&led Statetnent of Financial Actsiitses for the Year Ended 31 March 202? 31.3.22 31.3.21 LNCOIIE EI¥DOMThILJTS Donations and legacie5 Donations Gth aid 5,390 4,918 7,829 6.362 otber tridillg actiii¢les Fundraisjng ei.ents Other income 11,814 306 7,368 2,275 12,120 9.643 Charitable acthtldes TotAI Incomlng re5ource5 41,399 28,391 EXPE)TirrLryiE Cbarflable acthltles Wa8eg Pensio Insurance Telephone Postage & statioTh&y Leafiets and p)sters Sundn'es Sub&cripti¢)ns & re8thts.ons FundraisAn8 PaTrToII & HR IT & ..ebSite Consultanc) Trn8 Conferences O&A Toojknt Dep'n of iNEbsite 24,290 229 425 531 158 445 258 85 15,515 52 415 448 1,548 429 98 857 144 1.232 4,305 2,133 144 2,688 3,605 968 3,552 37,378 30.318 Support costs Goi"ernxnce costs Accoutttanej fees 640 620 38,018 30,938 Net incomeJ{e4Jenditure) (2 547) 23
Treated for cancer & living with the consequences?
We give a voice to people affected by Pelvic Radiation Disease
website | prda.org.uk office | 0113 278 5405 email | info@prda.org.uk
PelvicRadiationDisease
November 2022